NGM Biopharmaceuticals (NGM) Short Interest Ratio & Short Volume → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free NGM Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainability NGM Biopharmaceuticals Short Interest DataCurrent Short Volume2,390,000 sharesPrevious Short Volume1,680,000 sharesChange Vs. Previous Month+42.26%Dollar Volume Sold Short$3.80 millionShort Interest Ratio / Days to Cover2.2Last Record DateMarch 31, 2024Outstanding Shares83,462,000 sharesFloat Size52,820,000 sharesShort Percent of Float4.52%Today's Trading Volume2,390,800 sharesAverage Trading Volume1,467,160 sharesToday's Volume Vs. Average163% Short Selling NGM Biopharmaceuticals ? Sign up to receive the latest short interest report for NGM Biopharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNGM Short Interest Over TimeNGM Days to Cover Over TimeNGM Percentage of Float Shorted Over Time Ad AltimetryUrgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.Click here to access… NGM Biopharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20242,390,000 shares $3.80 million +42.3%4.5%2.2 $1.59 3/15/20241,680,000 shares $2.64 million +3.1%3.2%1.2 $1.57 2/29/20241,630,000 shares $2.48 million -1.8%3.1%1.3 $1.52 2/15/20241,660,000 shares $2.47 million -1.2%3.7%1.4 $1.49 1/31/20241,680,000 shares $2.57 million +9.1%4.1%1.7 $1.53 1/15/20241,540,000 shares $2.16 million -6.1%3.8%1.6 $1.40 Get the Latest News and Ratings for NGM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NGM Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/20231,640,000 shares $1.41 million -34.4%4.0%1.7 $0.86 12/15/20232,500,000 shares $1.88 million -1.6%5.6%5.4 $0.75 11/30/20232,540,000 shares $1.90 million -2.3%5.7%5.4 $0.75 11/15/20232,600,000 shares $1.77 million -2.3%5.8%5.1 $0.68 10/31/20232,660,000 shares $2.26 million +4.7%6.0%5.9 $0.85 10/15/20232,540,000 shares $2.90 million +3.7%5.7%5.8 $1.14 9/30/20232,450,000 shares $2.62 million +2.9%6.0%6.9 $1.07 9/15/20232,380,000 shares $3.12 million -5.6%5.3%7 $1.31 8/31/20232,520,000 shares $4.76 million -17.9%5.7%7.4 $1.89 8/15/20233,070,000 shares $6.29 million -6.1%6.9%9.7 $2.05 7/31/20233,270,000 shares $7.75 million -1.2%7.3%10.3 $2.37 7/15/20233,310,000 shares $9.20 million +4.1%7.7%10.3 $2.78 6/30/20233,180,000 shares $8.24 million -7.6%7.4%9.8 $2.59 6/15/20233,440,000 shares $12.18 million +7.2%8.0%10.9 $3.54 5/31/20233,210,000 shares $9.73 million -8.0%7.5%10.5 $3.03 5/15/20233,490,000 shares $11.62 million -7.4%8.4%11.6 $3.33 4/30/20233,770,000 shares $17.00 million +2.5%6.0%12.5 $4.51 4/15/20233,680,000 shares $13.25 million No Change5.9%11.8 $3.60 3/31/20233,680,000 shares $15.01 million +7.6%9.8%11.2 $4.08 3/15/20233,420,000 shares $13.00 million +10.7%9.1%9.9 $3.80 2/28/20233,090,000 shares $14.65 million +3.0%8.2%9 $4.74 2/15/20233,000,000 shares $14.10 million -3.2%7.9%8.3 $4.70 1/31/20233,100,000 shares $16.24 million +28.6%8.1%7.7 $5.24 1/15/20232,410,000 shares $12.77 million +13.7%6.3%3.7 $5.30 12/30/20222,120,000 shares $10.64 million +2.4%5.4%2.3 $5.02 12/15/20222,070,000 shares $10.78 million -16.9%5.3%2.2 $5.21 11/30/20222,490,000 shares $13.77 million +12.2%6.5%2.6 $5.53 11/15/20222,220,000 shares $12.32 million +2.8%5.8%2.3 $5.55 10/31/20222,160,000 shares $11.53 million -25.5%5.6%2.3 $5.34 10/15/20222,900,000 shares $33.50 million +8.6%7.5%3.3 $11.55 9/30/20222,670,000 shares $34.92 million +23.0%6.9%6.1 $13.08 9/15/20222,170,000 shares $33.48 million -6.5%6.8%4.6 $15.43 8/31/20222,320,000 shares $32.74 million -3.7%7.4%4.9 $14.11 8/15/20222,410,000 shares $42.49 million -4.4%7.7%5.2 $17.63Protect Your Bank Account Before It’s Too Late (Ad)For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself NGM Short Interest - Frequently Asked Questions What is NGM Biopharmaceuticals' current short interest? Short interest is the volume of NGM Biopharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 2,390,000 shares of NGM short. 4.52% of NGM Biopharmaceuticals' shares are currently sold short. Learn More on NGM Biopharmaceuticals' current short interest. What is a good short interest ratio for NGM Biopharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NGM shares currently have a short interest ratio of 2.0. Learn More on NGM Biopharmaceuticals's short interest ratio. What is a good short interest percentage for NGM Biopharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.52% of NGM Biopharmaceuticals' floating shares are currently sold short. Is NGM Biopharmaceuticals' short interest increasing or decreasing? NGM Biopharmaceuticals saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 2,390,000 shares, an increase of 42.3% from the previous total of 1,680,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is NGM Biopharmaceuticals' float size? NGM Biopharmaceuticals currently has issued a total of 83,462,000 shares. Some of NGM Biopharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NGM Biopharmaceuticals currently has a public float of 52,820,000 shares. How does NGM Biopharmaceuticals' short interest compare to its competitors? 4.52% of NGM Biopharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to NGM Biopharmaceuticals: LianBio (0.36%), So-Young International Inc. (0.04%), Karyopharm Therapeutics Inc. (14.59%), DBV Technologies S.A. (0.28%), Bright Health Group, Inc. (1.31%), Vaxart, Inc. (10.44%), Vistagen Therapeutics, Inc. (4.86%), Nuvectis Pharma, Inc. (13.15%), Abeona Therapeutics Inc (12.94%), Molecular Partners AG (0.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short NGM Biopharmaceuticals stock? Short selling NGM is an investing strategy that aims to generate trading profit from NGM Biopharmaceuticals as its price is falling. NGM shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NGM Biopharmaceuticals? A short squeeze for NGM Biopharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NGM, which in turn drives the price of the stock up even further. How often is NGM Biopharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NGM, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: LianBio Short Squeeze So-Young International Short Squeeze Karyopharm Therapeutics Short Squeeze DBV Technologies Short Squeeze Bright Health Group Short Squeeze Vaxart Short Squeeze Vistagen Therapeutics Short Squeeze Nuvectis Pharma Short Squeeze Abeona Therapeutics Short Squeeze Molecular Partners Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NGM) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithUrgent Nvidia WarningAltimetryThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorHe Is Giving Away BitcoinCrypto Swap ProfitsThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsHow Biden has already won 2024Porter & CompanyThe Crypto 9-5 Escape PlanCrypto 101 Media